Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Merkel Cell

Explore clinical trials studying Carcinoma, Merkel Cell. Study availability and eligibility vary by location and protocol.

106 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Merkel Cell trial results

Active, not recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details
Completed

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Completed

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

NCT03304639

Conditions
Adenocarcinoma, Advanced Merkel Cell Carcinoma, Carcinoma, +21 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 254 locations
View Trial Details
Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University - Siteman Cancer Center St Louis, Missouri, United States
View all 38 locations
View Trial Details
Completed

A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

NCT03599713

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of California San Francisco Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 65 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

NCT03783078

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States
  • Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States
  • Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia
  • Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia
View all 22 locations
View Trial Details
Completed

Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation

NCT02196961

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • University Hospital Essen, Dermatology Essen, North Rhine-Westphalia, Germany
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Elbeklinikum Buxtehude Buxtehude, Germany
  • University Hospital Dresden, Dermatology Dresden, Germany
View all 20 locations
View Trial Details

Related conditions